Stereotactic brachytherapy in low-grade gliomas

Oncology of CNS Tumors

Volumn , Issue , 2010, Pages 135-145

  Kreth, Friedrich W ^a   Mehrkens, Jan H ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866027775     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-02874-8_6     Document Type: Chapter

References (30)

1. Aarsen FK, Paquier PF, Reddingius RE, Streng IC, Arts WF, Evera-Preesman M, Catsman-Berrevoets CE. (2006) Functional outcome after low-grade astrocytoma treatment in childhood. Cancer 106:396-402
2. Bauman G, Lote K, Larson D, Stalpers L, Leighton C, Fisher B, Wara W, MacDonald D, Stitt L, Cairncross JG. (1999) Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. Int J Radiat Oncol Biol Phys 45:923-929
3. Bernstein M, Gutin PH. (1981) Interstitial irradiation of brain tumors: a review. Neurosurgery 6:741-750
4. Brenner DJ, Martel MK, Hall EJ. (1991) Fractionated regimes for stereotactic radiotherapy of recurrent tumors in the brain. Int J Radiat Oncol Biol Phys 21:819-824
5. Dale RG. (1985) The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol 58:515-528
6. Grasbon-Frodl EM, Kreth FW, Ruiter M, Schnell O, Bise K, Felsberg J, Reifenberger G, Tonn JC, Kretzschmar HA. (2007) Intratumoral homogeneity of MGMT promotor hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas. Int J Cancer 121:2458-2464
7. Groothuis DR, Wright DC, Ostertag CB. (1987) The effect of 125 I interstitial radiotherapy on blood-brain barrier function in normal canine brain. J Neurosurg 67:895-902
8. Karim ABMF, Maat B, Hatlevoll R, Menten J, Rutten EHJM, Thomas DGT, Mascarenhas F, Horiot JC, Parvinen LM, van Reijn M, Jager JJ, Fabrini MG, van Alphen AM, Hamers HP, Gaspar L, Noordman E, Pierart M, Glabbeke M. (1996) A randomized trial on dose response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 36:549-556
9. Karim AB, Afra D, Cornu P, Bleehan N, Schraub S, De Witte O, Darcel F, Stenning S, Pierart M, Van Glabbeke M. (2002) Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 52:316-324
10. Karnofsky DA, Burchenal JH. (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod M (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp. 191-205
11. Keles GE, Lundin DA, Lamborn KR, Chang EF, Ojemann G, Berger MS. (2004) Intraoperative subcortical stimulation mapping for hemispherical perirolandic glioma located within or adjacent to the descending motor pathways: evaluation of morbidity and assessment of functional outcome in 294 patients. J Neurosurg 100:369-375
12. Kondziolka, D, Lunsford LD, Martinez AJ. (1993) Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astro-cytoma. J Neurosurg 79:533-536
13. Kreth FW, Faist M, Warnke PC, Rossner R, Volk B, Ostertag CB. (1995) Stereotactic brachytherapy of low-grade gliomas. J Neurosurg 82:418-429
14. Kreth FW, Faist M, Rossner R, Birg W, Volk B, Ostertag CB. (1997) The risk of interstitial radiotherapy of low-grade gliomas. Radiother Oncol 43:253-260
15. Kreth FW, Faist M, Rossner R, Volk B, Ostertag CB. (1997) Supratentorial World Health Organization Grade 2 Astrocytomas and Oligoastrocytomas: a new pattern of prognostic factors. Cancer 79:370-379
16. Kreth FW, Faist M, Grau S, Ostertag CB. (2006) Interstitial 125I radiosurgery of supratentorial de novo WHO grade II astrocytoma and oligoastrocytoma in adults: long-term results and prognostic factors. Cancer 106:1372-1381
17. Krishnaswamy V. (1978) Dose distribution around a 125I seed source in tissue. Radiology 126:489-491
18. Lapierre NJ. (2000) Brachytherapy. In: Bernstein M, Berger MS (eds) Neuro-oncology: the essentials. Thieme, New York, pp. 200
19. Larsson B. (1992) Radiobiological fundamentals in radio-surgery. In: Steiner L (ed) Radiosurgery: baseline and trends. Raven, New York, pp. 3-14
20. Mehrkens JH, Kreth FW, Muacevic A, Ostertag CB. (2004) Long term course of WHO grade II astrocytomas of the Insula of Reil after I-125 interstitial irradiation. J Neurol 251(12):1455-1464
21. Muacevic A, Kreth FW. (2003) Significance of stereotactic biopsy for the management of WHO grade II supratentorial glioma. Nervenarzt 74:350-354
22. Mundinger F, Birg W, Ostertag CB. (1978) Treatment of small cerebral gliomas with CT-aided stereotaxic Curietherapy. Neuroradiology 16:564-567
23. Mundinger F, Braus DF, Krauss JK, Birg W. (1991) Long term outcome of 89 low-grade brain-stem gliomas after interstitial radiation therapy. J Neurosurg 75:740-746
24. Ostertag CB. (1998) Stereotactic brachytherapy of Brain Tumors. In: Gildenberg PL, Tasker RR (eds) Textbook of stereotactic and functional neurosurgery. McGraw-Hill, New York, pp. 589-598
25. Peraud A, Goetz C, Siefert A, Tonn JC, Kreth FW. (2007) Interstitial iodine-125 radiosurgery alone or in combination with microsurgery for pediatric patients with eloquently located low-grade glioma: a pilot study. Childs Nerv Syst 23:39-46
26. Pöpperl G, Kreth FW, Mehrkens JH, Herms J, Seelos K, Koch W, Gildehaus FJ, Kretzschmar HA, Tonn JC, Tatsch K. (2007) FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumor grading. Eur J Nucl Med Mol Imaging 12:1933-1942
27. Schnell O, Schöller K, Ruge M, Siefert A, Tonn JC, Kreth FW. (2008) Surgical resection plus stereotactic (125)I brachytherapy in adult patients with eloquently located supratentorial WHO grade II glioma-feasibility and outcome of a combined local treatment concept. J Neurol (Epub ahead of print)
28. Shaw E, Arusell R, Scheithauer B, O'Fallon J, O'Neill B, Dinapoli R, Nelson D, Earle J, Jones C, Cascino T, Nichols D, Ivnik R, Hellman R, Curran W, Abrams R. (2002) Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 20:2267-2276
29. Ständer M, Peraud A, Leroch B, Kreth FW. (2004) Prognostic impact of TP53 mutation status for adult patients with supraten-torial World Health Organization grade II astrocytoma or oli-goastrocytoma: a long-term analysis. Cancer 101:1028-1035
30. Weller M, Berger H, Hartmann C, Schramm J, Westphal M, Simon M, Goldbrunner R, Krex D, Steinbach JP, Ostertag CB, Loeffler M, Pietsch T, von Deimling A. (2007) German Glioma Network. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker? Clin Cancer Res 13:6933-6937